TY - JOUR
T1 - Gitelman-Like Syndrome Caused by Pathogenic Variants in mtDNA
AU - Genomics England Res Consortium
AU - Viering, Daan
AU - Schlingmann, Karl P.
AU - Hureaux, Marguerite
AU - Nijenhuis, Tom
AU - Mallett, Andrew
AU - Chan, Melanie M. Y.
AU - van Beek, Andre
AU - van Eerde, Albertien M.
AU - Coulibaly, Jean-Marie
AU - Vallet, Marion
AU - Decramer, Stephane
AU - Pelletier, Solenne
AU - Klaus, Gunter
AU - Komhoff, Martin
AU - Beetz, Rolf
AU - Patel, Chirag
AU - Shenoy, Mohan
AU - Steenbergen, Eric J.
AU - Anderson, Glenn
AU - Bongers, Ernie M. H. F.
AU - Bergmann, Carsten
AU - Panneman, Daan
AU - Rodenburg, Richard J.
AU - Kleta, Robert
AU - Houillier, Pascal
AU - Konrad, Martin
AU - Vargas-Poussou, Rosa
AU - Knoers, Nine V. A. M.
AU - Bockenhauer, Detlef
AU - de Baaij, Jeroen H. F.
PY - 2022/2
Y1 - 2022/2
N2 - Background Gitelman syndrome is the most frequent hereditary salt-losing tubulopathy characterized by hypokalemic alkalosis and hypomagnesemia. Gitelman syndrome is caused by biallelic pathogenic variants in SLC12A3, encoding the Na+-Cl- cotransporter (NCC) expressed in the distal convoluted tubule. Patho-genic variants of CLCNKB, HNF1B, FXYD2, or KCNJ10 may result in the same renal phenotype of Gitelman syndrome, as they can lead to reduced NCC activity. For approximately 10 percent of patients with a Gitelman syndrome phenotype, the genotype is unknown.Methods We identified mitochondrial DNA (mtDNA) variants in three families with Gitelman-like electro-lyte abnormalities, then investigated 156 families for variants in MT-TI and MT-TF, which encode the trans-fer RNAs for phenylalanine and isoleucine. Mitochondrial respiratory chain function was assessed in patient fibroblasts. Mitochondrial dysfunction was induced in NCC-expressing HEK293 cells to assess the effect on thiazide-sensitive Na-22(+) transport.Results Genetic investigations revealed four mtDNA variants in 13 families: m.591C > T (n=7), m.616T > C (n=1), m.643A > G (n=1) (all in MT-TF), and m.4291T > C (n=4, in MT-TI). Variants were near homoplasmic in affected individuals. All variants were classified as pathogenic, except for m.643A > G, which was classified as a variant of uncertain significance. Importantly, affected members of six families with an MT-TF variant additionally suffered from progressive chronic kidney disease. Dysfunction of oxidative phosphorylation complex IV and reduced maximal mitochondrial respiratory capacity were found in patient fibroblasts. In vitro pharmacological inhibition of complex IV, mimicking the effect of the mtDNA variants, inhibited NCC phosphorylation and NCC-mediated sodium uptake.Conclusion Pathogenic mtDNA variants in MT-TF and MT-TI can cause a Gitelman-like syndrome. Genetic investigation of mtDNA should be considered in patients with unexplained Gitelman syndrome-like tubulopathies.
AB - Background Gitelman syndrome is the most frequent hereditary salt-losing tubulopathy characterized by hypokalemic alkalosis and hypomagnesemia. Gitelman syndrome is caused by biallelic pathogenic variants in SLC12A3, encoding the Na+-Cl- cotransporter (NCC) expressed in the distal convoluted tubule. Patho-genic variants of CLCNKB, HNF1B, FXYD2, or KCNJ10 may result in the same renal phenotype of Gitelman syndrome, as they can lead to reduced NCC activity. For approximately 10 percent of patients with a Gitelman syndrome phenotype, the genotype is unknown.Methods We identified mitochondrial DNA (mtDNA) variants in three families with Gitelman-like electro-lyte abnormalities, then investigated 156 families for variants in MT-TI and MT-TF, which encode the trans-fer RNAs for phenylalanine and isoleucine. Mitochondrial respiratory chain function was assessed in patient fibroblasts. Mitochondrial dysfunction was induced in NCC-expressing HEK293 cells to assess the effect on thiazide-sensitive Na-22(+) transport.Results Genetic investigations revealed four mtDNA variants in 13 families: m.591C > T (n=7), m.616T > C (n=1), m.643A > G (n=1) (all in MT-TF), and m.4291T > C (n=4, in MT-TI). Variants were near homoplasmic in affected individuals. All variants were classified as pathogenic, except for m.643A > G, which was classified as a variant of uncertain significance. Importantly, affected members of six families with an MT-TF variant additionally suffered from progressive chronic kidney disease. Dysfunction of oxidative phosphorylation complex IV and reduced maximal mitochondrial respiratory capacity were found in patient fibroblasts. In vitro pharmacological inhibition of complex IV, mimicking the effect of the mtDNA variants, inhibited NCC phosphorylation and NCC-mediated sodium uptake.Conclusion Pathogenic mtDNA variants in MT-TF and MT-TI can cause a Gitelman-like syndrome. Genetic investigation of mtDNA should be considered in patients with unexplained Gitelman syndrome-like tubulopathies.
KW - epithelial sodium transport
KW - genetic renal disease
KW - human genetics
KW - Na transport
KW - ion transport
KW - mitochondria
KW - Gitelman-s syndrome
KW - blood pressure
KW - chronic kidney disease
KW - chronic kidney failure
KW - SODIUM-CHLORIDE COTRANSPORTER
KW - MITOCHONDRIAL-DNA MUTATION
KW - BARTTER-SYNDROME
KW - CHANNEL GENE
KW - MAGNESIUM
KW - DISEASE
KW - TUBULE
KW - NCC
KW - PHOSPHORYLATION
KW - HYPOMAGNESEMIA
U2 - 10.1681/ASN.2021050596
DO - 10.1681/ASN.2021050596
M3 - Article
SN - 1046-6673
VL - 33
SP - 305
EP - 325
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 2
ER -